April 4 (Reuters) - Sarepta Therapeutics Inc SRPT.O:
SAREPTA THERAPEUTICS PROVIDES UPDATE ON ELEVIDYS
SAREPTA THERAPEUTICS: STUDIES AFFECTED BY TEMPORARY HALT ARE STUDY SRP-9001-302 (ENVOL), STUDY SRP-9001-303 (ENVISION), STUDY SRP-9001-104
SAREPTA THERAPEUTICS: CO, ROCHE WILL SUBMIT INFORMATION IN RESPONSE TO TEMPORARY HALT WITHIN WEEK
SAREPTA THERAPEUTICS INC -DO NOT ANTICIPATE A MATERIAL IMPACT ON TIMELINE FOR SRP-9001-302, SRP-9001-303, SRP-9001-104 STUDIES
Source text: ID:nBw4vsDXGa
Further company coverage: SRPT.O
(((( Reuters.briefs@thomsonreuters.com ;));))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.